SIgnatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer
NCT07214532 · RECRUITING · N/A
We track 1 ClinicalTrials.gov studies led by Natera Inc. The portfolio skews toward N/A (1 trials).
1 clinical trials sponsored by Natera Inc.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 1 | 100% |
Natera Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span N/A.
Natera Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Natera Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.